Literature DB >> 21087542

Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization.

F Dijkstra1, J Riphagen-Dalhuisen, N Wijers, E Hak, M A B Van der Sande, G Morroy, P M Schneeberger, B Schimmer, D W Notermans, W Van der Hoek.   

Abstract

Data about the effectiveness of different antibiotic regimens for the treatment of acute Q fever from clinical studies is scarce. We analysed the antibiotic treatment regimens of acute Q fever patients in 2007 and 2008 in The Netherlands and assessed whether hospitalization after a minimum of 2 days antibiotic therapy was related to the initial antibiotic therapy. Clinical data on antibiotic treatment and risk factors of acute Q fever patients were obtained from general practitioner medical records and self-reported by patients. For the 438 study patients, doxycycline was the most commonly prescribed initial antibiotic in both study years. After adjustments for confounding factors, doxycycline (200 mg/day), moxifloxacin, as well as other possibly effective antibiotics [including other new fluoroquinolones and doxycycline (100 mg/day)] showed significant lower risks for hospitalization compared to β-lactam antibiotics and azithromycin (reference group), with the lowest risk for doxycycline (200 mg/day) (odds ratio 0·04, 95% confidence interval 0·01-0·22). These data support current guidelines that recommend doxycycline as the first choice antibiotic for treating acute Q fever.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087542     DOI: 10.1017/S0950268810002621

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Etiologies of illness among patients meeting integrated management of adolescent and adult illness district clinician manual criteria for severe infections in northern Tanzania: implications for empiric antimicrobial therapy.

Authors:  Matthew P Rubach; Venance P Maro; John A Bartlett; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

3.  Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic.

Authors:  Cornelia C H Wielders; Joris A F van Loenhout; Gabriëlla Morroy; Ariene Rietveld; Daan W Notermans; Peter C Wever; Nicole H M Renders; Alexander C A P Leenders; Wim van der Hoek; Peter M Schneeberger
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

4.  Case Report: Metagenomic Next-Generation Sequencing Clinches the Diagnosis of Acute Q Fever and Verified by Indirect Immunofluorescence Assay.

Authors:  Yide Yang; Qingmiao Shi; Qian Jin; Zhangnv Yang; Wangfang Li; Jianfeng Han; Juanjuan Mao; Beiwen Zheng
Journal:  Front Med (Lausanne)       Date:  2022-05-26

5.  Early diagnosis and treatment of patients with symptomatic acute Q fever do not prohibit IgG antibody responses to Coxiella burnetii.

Authors:  C C H Wielders; L M Kampschreur; P M Schneeberger; M M Jager; A I M Hoepelman; A C A P Leenders; M H A Hermans; P C Wever
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

6.  Coxiella burnetii Infection in a Community Operating a Large-Scale Cow and Goat Dairy, Missouri, 2013.

Authors:  Holly M Biggs; George Turabelidze; Drew Pratt; Suzanne R Todd; Kara Jacobs-Slifka; Naomi A Drexler; Gail McCurdy; Jennifer Lloyd; Charles L Evavold; Kelly A Fitzpatrick; Rachael A Priestley; Joseph Singleton; David Sun; Minh Tang; Cecilia Kato; Gilbert J Kersh; Alicia Anderson
Journal:  Am J Trop Med Hyg       Date:  2016-01-25       Impact factor: 2.345

7.  Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease.

Authors:  J A F van Loenhout; C C H Wielders; G Morroy; M J M Cox; W van der Hoek; J L A Hautvast; W J Paget; J van der Velden
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

8.  Differentiation of Acute Q Fever from Other Infections in Patients Presenting to Hospitals, the Netherlands

Authors:  Stephan P Keijmel; Elmer Krijger; Corine E Delsing; Tom Sprong; Marrigje H Nabuurs-Franssen; Chantal P Bleeker-Rovers
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

9.  Characteristics of hospitalized acute Q fever patients during a large epidemic, The Netherlands.

Authors:  Cornelia C H Wielders; Annemarie M H Wuister; Veerle L de Visser; Monique G de Jager-Leclercq; Cornelis A R Groot; Frederika Dijkstra; Arianne B van Gageldonk-Lafeber; Jeroen P G van Leuken; Peter C Wever; Wim van der Hoek; Peter M Schneeberger
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 10.  Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine.

Authors:  Patrick M Reeves; Susan Raju Paul; Ann E Sluder; Timothy A Brauns; Mark C Poznansky
Journal:  Hum Vaccin Immunother       Date:  2017-09-21       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.